Cargando…

Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'

Detalles Bibliográficos
Autores principales: Jara-Palomares, Luis, Asensio-Cruz, Maria Isabel, Elias-Hernandez, Teresa, Marin-Romero, Samira, Otero-Candelera, Remedios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461950/
https://www.ncbi.nlm.nih.gov/pubmed/30696982
http://dx.doi.org/10.1038/s41416-018-0362-9
_version_ 1783410557000351744
author Jara-Palomares, Luis
Asensio-Cruz, Maria Isabel
Elias-Hernandez, Teresa
Marin-Romero, Samira
Otero-Candelera, Remedios
author_facet Jara-Palomares, Luis
Asensio-Cruz, Maria Isabel
Elias-Hernandez, Teresa
Marin-Romero, Samira
Otero-Candelera, Remedios
author_sort Jara-Palomares, Luis
collection PubMed
description
format Online
Article
Text
id pubmed-6461950
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64619502020-01-30 Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis' Jara-Palomares, Luis Asensio-Cruz, Maria Isabel Elias-Hernandez, Teresa Marin-Romero, Samira Otero-Candelera, Remedios Br J Cancer Correspondence Nature Publishing Group UK 2019-01-30 2019-02-19 /pmc/articles/PMC6461950/ /pubmed/30696982 http://dx.doi.org/10.1038/s41416-018-0362-9 Text en © Cancer Research UK 2019 https://creativecommons.org/licenses/by/4.0/This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Correspondence
Jara-Palomares, Luis
Asensio-Cruz, Maria Isabel
Elias-Hernandez, Teresa
Marin-Romero, Samira
Otero-Candelera, Remedios
Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_full Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_fullStr Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_full_unstemmed Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_short Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_sort reply to comment on 'd-dimer and high-sensitivity c-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461950/
https://www.ncbi.nlm.nih.gov/pubmed/30696982
http://dx.doi.org/10.1038/s41416-018-0362-9
work_keys_str_mv AT jarapalomaresluis replytocommentonddimerandhighsensitivitycreactiveproteinlevelstopredictvenousthromboembolismrecurrenceafterdiscontinuationofanticoagulationforcancerassociatedthrombosis
AT asensiocruzmariaisabel replytocommentonddimerandhighsensitivitycreactiveproteinlevelstopredictvenousthromboembolismrecurrenceafterdiscontinuationofanticoagulationforcancerassociatedthrombosis
AT eliashernandezteresa replytocommentonddimerandhighsensitivitycreactiveproteinlevelstopredictvenousthromboembolismrecurrenceafterdiscontinuationofanticoagulationforcancerassociatedthrombosis
AT marinromerosamira replytocommentonddimerandhighsensitivitycreactiveproteinlevelstopredictvenousthromboembolismrecurrenceafterdiscontinuationofanticoagulationforcancerassociatedthrombosis
AT oterocandeleraremedios replytocommentonddimerandhighsensitivitycreactiveproteinlevelstopredictvenousthromboembolismrecurrenceafterdiscontinuationofanticoagulationforcancerassociatedthrombosis